359 related articles for article (PubMed ID: 32743745)
1. The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.
Lau HHC; Ingelsson M; Watts JC
Acta Neuropathol; 2021 Jul; 142(1):17-39. PubMed ID: 32743745
[TBL] [Abstract][Full Text] [Related]
2. Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.
Condello C; Stöehr J
Neurobiol Dis; 2018 Jan; 109(Pt B):191-200. PubMed ID: 28359847
[TBL] [Abstract][Full Text] [Related]
3. β-Amyloid Prions and the Pathobiology of Alzheimer's Disease.
Watts JC; Prusiner SB
Cold Spring Harb Perspect Med; 2018 May; 8(5):. PubMed ID: 28193770
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
5. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
[TBL] [Abstract][Full Text] [Related]
6. Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.
Walker LC
Annu Rev Genet; 2016 Nov; 50():329-346. PubMed ID: 27893962
[TBL] [Abstract][Full Text] [Related]
7. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.
Rossi M; Kai H; Baiardi S; Bartoletti-Stella A; Carlà B; Zenesini C; Capellari S; Kitamoto T; Parchi P
Acta Neuropathol Commun; 2019 Apr; 7(1):53. PubMed ID: 30961668
[TBL] [Abstract][Full Text] [Related]
8. From soluble aβ to progressive aβ aggregation: could prion-like templated misfolding play a role?
Eisele YS
Brain Pathol; 2013 May; 23(3):333-41. PubMed ID: 23587139
[TBL] [Abstract][Full Text] [Related]
9. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
10. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
[TBL] [Abstract][Full Text] [Related]
11. Strains of Pathological Protein Aggregates in Neurodegenerative Diseases.
Wang X; Noroozian Z; Lynch M; Armstrong N; Schneider R; Liu M; Ghodrati F; Zhang AB; Yang YJ; Hall AC; Solarski M; Killackey SA; Watts JC
Discoveries (Craiova); 2017 Sep; 5(3):e78. PubMed ID: 32309596
[TBL] [Abstract][Full Text] [Related]
12. The Prion-like Properties of Amyloid-beta Peptide and Tau: Is there Any Risk of Transmitting Alzheimer's Disease During Neurosurgical Interventions?
Padilla-Zambrano HS; García-Ballestas E; Quiñones-Ossa GA; Sibaja-Perez AE; Agrawal A; Moscote-Salazar LR; Menéndez-González M
Curr Alzheimer Res; 2020; 17(9):781-789. PubMed ID: 33280597
[TBL] [Abstract][Full Text] [Related]
13. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.
Catania M; Di Fede G
Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234
[TBL] [Abstract][Full Text] [Related]
14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
15. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
Jeffrey M
Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
[TBL] [Abstract][Full Text] [Related]
16. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
17. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice.
Ruiz-Riquelme A; Mao A; Barghash MM; Lau HHC; Stuart E; Kovacs GG; Nilsson KPR; Fraser PE; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2021 May; 9(1):83. PubMed ID: 33971978
[TBL] [Abstract][Full Text] [Related]
18. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
Thal DR; Walter J; Saido TC; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
[TBL] [Abstract][Full Text] [Related]
19. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
20. Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.
Hatami A; Monjazeb S; Milton S; Glabe CG
J Biol Chem; 2017 Feb; 292(8):3172-3185. PubMed ID: 28049728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
